HPV project banner
HOT TOPIC: ADOLESCENT VACCINE AND QUALITY

ImagePack Vaccine I s your practice part of an initiative to improve healthcare quality? Many practices immediately think about diabetes, asthma, and hypertension, but immunizations are preventive measures that cross the lifespan of quality care from infants through adulthood.

Healthy People 2020 provides a comprehensive set of 10-year national goals and objectives designed to guide national health promotion and disease prevention for all people in the United States. 

For three decades, Healthy People has established benchmarks and monitored progress over time in order to:
  • Encourage collaborations across communities and sectors
  • Empower individuals toward making informed health decisions
  • Measure the impact of prevention activities
The mission of Healthy People 2020 strives to:
  • Identify nationwide health improvement priorities
  • Increase public awareness and understanding of the determinants of health, disease, and disability and the opportunities for progress
  • Provide measurable objectives and goals that are applicable at the national, state, and local levels
  • Engage multiple sectors to take actions to strengthen policies and improve practices that are driven by the best available evidence and knowledge
  • Identify critical research, evaluation, and data collection needs
healthy people 2020 outlines adolescent vaccine goals

success Healthy People 2020 has the following goals for adolescent vaccinations:
  • Increase the vaccination coverage of 1 dose of tetanus-diptheria-acellular pertussis (Tdap) booster vaccine for adolescents by age 13 to 15 years
    • Target - 80%
  • Increase the vaccination coverage level of one dose meningococcal conjugate vaccine for adolescents by age 13 to 15 years
    • Target - 80%
  • Increase the vaccination coverage level of three doses of human papillomavirus (HPV) vaccine for females by age 13 to 15 years
    • Target - 80%
  • Increase the vaccination coverage level of 3 doses of human papillomavirus (HPV) vaccine for males by age 13 to 15 years
    • Target - 80%
hpv graph
use the Healthy People 2020 Progress Tracker to see key health status indicators for delaware 

group Healthy People 2020 provides a framework for prevention for communities in the U.S. Healthy People 2020 is a comprehensive set of key disease prevention and health promotion objectives. The health objectives and targets allow communities to assess their health status and build an agenda for community health improvement. Click here to access the 2020 Progress Tracker to view Delaware statistics

CDC TeenVaxView
You can also track Delaware's vaccination rate progress at  the CDC TeenVaxView. According to TeenVaxView, D elaware had a rate of 53.4 percent of females aged 13-17 receiving two or more doses of HPV vaccine in 2008. This rate steadily increased to 61.3 percent for both males and females in 2016.

What can you do to improve vaccination rates?
Your practice can help meet these goals by recommending and/or vaccinating adolescent patients today. How do you know how your office is doing? The National Quality Forum (NQF) is a not-for-profit organization that works to endorse standards used to measure and report on quality and efficiency. By knowing your NQF baseline metrics, you will have a starting point for practice transformation.  
 
You may also be aware of the Healthcare Effectiveness Data and Information Set (HEDIS), which is a tool used by more than 90 percent of America's health plans to measure performance on important dimensions of care and service. Because so many plans use HEDIS and because the measures are so specifically defined, HEDIS can be used to make comparisons among plans. Your HEDIS rate
is a good reflection of how you are doing to achieve Healthy people goals. 

If your practice in a Federally Qualified Health Center (FQHC) or Rural Health Clinic (RHC), you may be more familiar with Uniform Data System (UDS) measurements. 

Whatever metric you use, best practices show that knowing your rates is a foundation to transformational success.
Science corner: WHY VACCINATE AT 11 OR 12?

There are both logistical and scientific reasons to vaccinate an 11 or 12 year old at their next visit.  Scientifically, preteens have a higher immune response to HPV vaccine than older teens and younger adults. The licensed HPV vaccines have demonstrated extraordinary immunogenicity and efficacy. It is important to point out that the correlate of protection (minimum immune response) has not been defined, and that there are both preclinical and clinical evidence to support that neutralizing antibodies is the main mechanism of protection.
 
What can your office consider logistically to maximize on missed opportunities? As teens get older, they make less frequent visits to the doctor. Here are some tips to improving vaccination rates within your teenage patient population:
  • Administer vaccinations at various visit types (sick, sports physicals, follow-up visits)
  • Issue a standing order to allow nurses to vaccinate
  • Implement clinical reminders
  • Schedule the patient before he or she leaves for the next dose
Also, check out the Academic Pediatrics March 2018 Journal, Volume 18, Issue 2 Supplement for a series of articles on improving HPV vaccination rates.

exclamation point icon Resource Alert
The  Clinician FAQ: CDC Recommendation for HPV Vaccine 2-Dose Schedules  is a great resource from the Centers of Disease Control and Prevention (CDC) that provides a review of updated recommendations, dosing schedules, and better protection against HPV at ages 11-12. 
patient perspective: 
videos show the impact of cancer from the human point of view

video This month, Quality Insights continues to share the human perspective of having HPV related cancers.  In the first video, Tamika Felder, a cervical cancer survivor, provides her perspective on surgery and treatment. In the second video, Dr. Cherie Ann Nathan offers her insights on head and neck cancers.
educational event: Join the HPV Roundtable Webinar to Showcase ACS's Mission HPV Cancer Free

e-learning Wednesday, May 30, 2018 at 2:00 p.m.
 
The National HPV Vaccination Roundtable invites you to attend a webinar which will provide an overview of the American Cancer Society's (ACS) Mission HPV Cancer Free campaign and ways organizations can partner with ACS over the summer and beyond.
 
During this hour, ACS will:
  • Present an overview of Mission: HPV Cancer Free goals and objectives
  • Present a resource guide for partners in support of HPV cancer prevention
  • Host a Q/A session 
While registration is not required, capacity is limited to the first 500 participants. The webinar will be recorded and posted on the HPV Roundtable website.
coalition & society news: HPV RESOURCES AT YOUR FINGERTIPS

news icon The National HPV Vaccination Roundtable is a trusted coalition of public, private, and voluntary organizations and experts dedicated to reducing incidence of and mortality from HPV cancers in the United States. Its website provides an array of fantastic resources. Here are just some of the great tools you'll find:

register now a free CME/CE webinar
you are the key: best practices for hpv cancer 

Tuesday, June 12, 2018
2:00 to 3:00 p.m. 

Low HPV vaccination rates are leaving boys and girls vulnerable to devastating HPV cancers. Have you been making an effective HPV vaccination recommendation for kids 11 and 12 years old? 

This presentation will provide up-to-date information on HPV infection/disease, the HPV vaccine, ACIP recommendations, and ways to successfully communicate with patients and their parents about HPV vaccination. 

Find out how to reduce missed opportunities by recommending HPV vaccine the same way and same day you recommend other routinely recommended adolescent vaccines, and learn best practices from other medical offices across the nation that are making HPV vaccination a priority.
"Vaccines save lives; fear endangers them, it's a simple message 
parents need to keep hearing."

- Jeffrey Kluger
contact information

For more details about the HPV Vaccine Improvement Project , please contact Lisa Gruss.

Quality Insights logo      
This project is in collaboration with the Division of Public Health (DPH) - Comprehensive Cancer Control Program, Immunization and Vaccines 
for Children, and the Centers for Disease Control and Prevention (CDC). Publication number DEDPH-HPV-051518